Karunya Kandimalla

Assistant Professor

University of Minnesota

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Karunya Kandimalla is an Assistant Professor at the University of Minnesota, United States. His research focuses on the interactions of insulin signaling and amyloid beta peptides at the blood-brain barrier, with recent publications exploring intracellular trafficking, glucose transport inhibition, and pathological synergism in neurodegenerative diseases. Additionally, his work includes modeling pharmacokinetics related to amyloid beta exposure and addressing COVID-19 therapeutic strategies.

Articles (8)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Collaborators (1)

Sunil Krishnan

Professor

The University of Texas Health Science Center at Houston

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Karunya Kandimalla

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

QSP Modeling Shows Pathological Synergism Between Insulin Resistance and Amyloid‐Beta Exposure in Upregulating VCAM1 Expression at the BBB Endothelium

Intracellular Trafficking of Cationic Bicelles and siRNA Cargo in an In Vitro Blood–Brain Barrier Model

Amyloid beta peptides inhibit glucose transport at the blood-brain barrier by disrupting the insulin-AKT pathway

High-Density Lipoprotein Mimetic Peptide 4F Reduces Toxic Amyloid-Beta Exposure to the Blood-Brain Barrier Endothelium in Alzheimer’s Disease Transgenic Mice

Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood–Brain Barrier

Mapping the dynamics of insulin-responsive pathways in the blood–brain barrier endothelium using time-series transcriptomics data

Semimechanistic Population Pharmacokinetic Modeling to Investigate Amyloid Beta Trafficking and Accumulation at the BBB Endothelium

COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies

Collaborators (1)

Sunil Krishnan

Make your next move.